PT70614A - Procede pour la preparation de compositions galeniques solides a effet prolonge - Google Patents

Procede pour la preparation de compositions galeniques solides a effet prolonge

Info

Publication number
PT70614A
PT70614A PT70614A PT7061479A PT70614A PT 70614 A PT70614 A PT 70614A PT 70614 A PT70614 A PT 70614A PT 7061479 A PT7061479 A PT 7061479A PT 70614 A PT70614 A PT 70614A
Authority
PT
Portugal
Prior art keywords
preparation
prolonged effect
galenic compositions
solid galenic
solid
Prior art date
Application number
PT70614A
Other languages
English (en)
French (fr)
Portuguese (pt)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT70614A publication Critical patent/PT70614A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT70614A 1978-12-21 1979-12-19 Procede pour la preparation de compositions galeniques solides a effet prolonge PT70614A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1302178 1978-12-21
CH1301978 1978-12-21
CH56679 1979-01-19
CH56779 1979-01-19

Publications (1)

Publication Number Publication Date
PT70614A true PT70614A (fr) 1980-01-01

Family

ID=27427929

Family Applications (1)

Application Number Title Priority Date Filing Date
PT70614A PT70614A (fr) 1978-12-21 1979-12-19 Procede pour la preparation de compositions galeniques solides a effet prolonge

Country Status (23)

Country Link
AT (1) AT372279B (no)
AU (1) AU534051B2 (no)
CA (1) CA1139222A (no)
CH (1) CH642259A5 (no)
CY (1) CY1330A (no)
DE (1) DE2950154A1 (no)
DK (1) DK154607C (no)
FI (1) FI793888A (no)
FR (1) FR2444463A1 (no)
GB (1) GB2038181B (no)
HK (1) HK37986A (no)
HU (1) HU182577B (no)
IE (1) IE49323B1 (no)
IL (1) IL59003A (no)
IT (1) IT1164029B (no)
KE (1) KE3617D (no)
MY (1) MY8500129A (no)
NL (1) NL187229C (no)
NZ (1) NZ192457A (no)
PH (1) PH25178A (no)
PT (1) PT70614A (no)
SE (1) SE442265B (no)
WO (1) WO1980001242A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE14379T1 (de) * 1981-04-27 1985-08-15 Haessle Ab Pharmazeutisches praeparat.
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
DE3413955A1 (de) * 1983-04-22 1984-10-25 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutisches praeparat enthaltend co-dergocrine und einen calcium-antagonisten
HU192050B (en) * 1983-04-22 1987-05-28 Sandoz Ag Process for production of medical preparative containing co-dergocrin and one piridin-dicarbonic acid diesthertype calcium-antagonist
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
AT388101B (de) * 1985-02-05 1989-05-10 Sandoz Ag Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur oralen verabreichung mit kontrollierter wirkstofffreisetzung
CN1003978B (zh) * 1987-09-05 1989-04-26 广州陈李济药厂 一种补脾益肠丸的制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
DE2528257C2 (de) * 1974-07-04 1986-02-13 Sandoz-Patent-GmbH, 7850 Lörrach Neue galenische Zubereitung
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Also Published As

Publication number Publication date
IT7951153A0 (it) 1979-12-20
CH642259A5 (de) 1984-04-13
DK154607C (da) 1989-06-05
FR2444463B1 (no) 1983-02-25
CY1330A (en) 1986-06-27
HK37986A (en) 1986-05-30
DK154607B (da) 1988-12-05
GB2038181A (en) 1980-07-23
HU182577B (en) 1984-02-28
WO1980001242A1 (en) 1980-06-26
DE2950154C2 (no) 1989-05-11
GB2038181B (en) 1983-05-11
IE792471L (en) 1980-06-21
CA1139222A (en) 1983-01-11
IL59003A (en) 1982-12-31
IE49323B1 (en) 1985-09-18
ATA803679A (de) 1983-02-15
KE3617D (en) 1986-04-18
AU5403179A (en) 1980-06-26
FI793888A (fi) 1980-06-22
SE7910227L (sv) 1980-06-22
PH25178A (en) 1991-03-27
DE2950154A1 (de) 1980-07-10
AU534051B2 (en) 1984-01-05
DK529879A (da) 1980-06-22
NL7909105A (nl) 1980-06-24
IT1164029B (it) 1987-04-08
AT372279B (de) 1983-09-26
NL187229C (nl) 1991-07-16
FR2444463A1 (fr) 1980-07-18
MY8500129A (en) 1985-12-31
SE442265B (sv) 1985-12-16
NZ192457A (en) 1983-06-17

Similar Documents

Publication Publication Date Title
PT69309A (fr) Procede pour la production de compositions galeniques
MC1336A1 (fr) Procede pour la preparation de compositions pharmaceutiques
RO75099A (ro) Procedeu de preparare a unor compozitii stabile de antibiotice continind tetraciclina
RO76393A (ro) Procedeu de preparare a unor n-(2'-pirolidilmetil)-2-metoxi-4-amino-5-alchilsulfonilbenzamide
RO78105A (ro) Procedeu pentru prepararea unor 2-clor-6-nitroaniline
RO76889A (ro) Procedeu de preparare a unor 8-metoximetilergoline sau 8-metilmercaptometilergoline
RO78870A (ro) Procedeu pentru prepararea unor derivati de mercaptoacilproline
RO83454A (ro) Procedeu pentru prepararea unor pirimidoane
RO83052A (ro) Procedeu pentru prepararea unor derivati de fenetanolamina
RO82375A (ro) Procedeu pentru prepararea de derivati ai 9-aminodibenzopiran
RO81037A (ro) Procedeu de preparare a unor 4-dezacelil-vincaleucoblastin-c3-carboxuhydrazide
RO76935A (ro) Procedeu pentru prepararea unor benzofenonhidrazone
BE877261A (fr) Procede pour eviter l'effet de pompage de turbocompresseurs
FR2421170B1 (fr) Procede pour la preparation de 2,2,6,6-tetramethyl-4-piperidone
RO76562A (fr) Procede pour la preparation des 3-imidazolilbenzo-1,2,4-triazine-1-oxydes
PT66174A (fr) Procede pour la preparation de derives de ditiole-1,2 et de compositions qu'en contiennent
RO82359A (ro) Procedeu pentru prepararea unor 4-tiazolidinone
RO78225A (ro) Procedeu pentru prepararea unor 3,4-dihidro-3-oxo-2-chinoxaline
PT70614A (fr) Procede pour la preparation de compositions galeniques solides a effet prolonge
PT69815A (fr) Procede de preparation de l' o-methallyloxyphenol
BE884153A (fr) Procede de preparation de compositions pharmaceutiques se desagregeant aisement
RO78631A (ro) Procedeu pentru prepararea unor compusi ai fosfonometilglicinei
RO78091A (ro) Procedeu pentru prepararea unor derivati de 1-azoletena
RO76936A (ro) Procedeu pentru prepararea de p-fenilendiamine asimetrice n-fenil-n'-substituite
BE875378A (fr) Procede de preparation d'alcoylsilanes

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19940807